The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Glucocorticoid API Market Research Report 2025
Synopsis
Glucocorticoid APIs are chemical raw materials used to synthesize glucocorticoid drugs. Glucocorticoids (or, less commonly, glucocorticosteroids) are a class of corticosteroids, which are a class of steroid hormones.
The global Glucocorticoid API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Glucocorticoid API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Glucocorticoid API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Glucocorticoid API include Pfizer CentreOne, EUROAPI, GlaxoSmithKline, Tianjin Tianyao Pharmaceuticals, Zhejiang Xianju Pharmaceutical, Henan Lihua Pharmaceutical, Symbiotec Pharmalab, Sun Pharmaceutical, Cipla, Hovione, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Glucocorticoid API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucocorticoid API.
The Glucocorticoid API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Glucocorticoid API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glucocorticoid API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer CentreOne
EUROAPI
GlaxoSmithKline
Tianjin Tianyao Pharmaceuticals
Zhejiang Xianju Pharmaceutical
Henan Lihua Pharmaceutical
Symbiotec Pharmalab
Sun Pharmaceutical
Cipla
Hovione
Shandong Xinhua Pharmaceutical
Steroid SpA
Avik Pharmaceutical
Great Pacific Exports
Shanghai New Hualian Pharmaceutical
Shandong Taihua Biotech
Tianjin Pacific Pharmaceutical
Teva
Zhejiang Xianju Xianle Pharmaceutical
Jiangsu Lianhuan Pharmaceutical
Saituo Biological Technology
Segment by Type
Prednisone Series
Dexamethasone Series
Methylprednisolone Series
Prednisolone Series
Hydrocortisone Series
Others
Segment by Application
Injectable Preparations
Oral Preparations
Topical Preparations
Inhaled Preparations
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glucocorticoid API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glucocorticoid API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Glucocorticoid APIs are chemical raw materials used to synthesize glucocorticoid drugs. Glucocorticoids (or, less commonly, glucocorticosteroids) are a class of corticosteroids, which are a class of steroid hormones.
The global Glucocorticoid API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Glucocorticoid API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Glucocorticoid API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Glucocorticoid API include Pfizer CentreOne, EUROAPI, GlaxoSmithKline, Tianjin Tianyao Pharmaceuticals, Zhejiang Xianju Pharmaceutical, Henan Lihua Pharmaceutical, Symbiotec Pharmalab, Sun Pharmaceutical, Cipla, Hovione, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Glucocorticoid API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucocorticoid API.
The Glucocorticoid API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Glucocorticoid API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glucocorticoid API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer CentreOne
EUROAPI
GlaxoSmithKline
Tianjin Tianyao Pharmaceuticals
Zhejiang Xianju Pharmaceutical
Henan Lihua Pharmaceutical
Symbiotec Pharmalab
Sun Pharmaceutical
Cipla
Hovione
Shandong Xinhua Pharmaceutical
Steroid SpA
Avik Pharmaceutical
Great Pacific Exports
Shanghai New Hualian Pharmaceutical
Shandong Taihua Biotech
Tianjin Pacific Pharmaceutical
Teva
Zhejiang Xianju Xianle Pharmaceutical
Jiangsu Lianhuan Pharmaceutical
Saituo Biological Technology
Segment by Type
Prednisone Series
Dexamethasone Series
Methylprednisolone Series
Prednisolone Series
Hydrocortisone Series
Others
Segment by Application
Injectable Preparations
Oral Preparations
Topical Preparations
Inhaled Preparations
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glucocorticoid API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glucocorticoid API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Glucocorticoid API Market Overview
1.1 Product Definition
1.2 Glucocorticoid API by Type
1.2.1 Global Glucocorticoid API Market Value Comparison by Type (2024-2030)
1.2.2 Prednisone Series
1.2.3 Dexamethasone Series
1.2.4 Methylprednisolone Series
1.2.5 Prednisolone Series
1.2.6 Hydrocortisone Series
1.2.7 Others
1.3 Glucocorticoid API by Application
1.3.1 Global Glucocorticoid API Market Value by Application (2024-2030)
1.3.2 Injectable Preparations
1.3.3 Oral Preparations
1.3.4 Topical Preparations
1.3.5 Inhaled Preparations
1.4 Global Glucocorticoid API Market Size Estimates and Forecasts
1.4.1 Global Glucocorticoid API Revenue 2019-2030
1.4.2 Global Glucocorticoid API Sales 2019-2030
1.4.3 Global Glucocorticoid API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Glucocorticoid API Market Competition by Manufacturers
2.1 Global Glucocorticoid API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Glucocorticoid API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Glucocorticoid API Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Glucocorticoid API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glucocorticoid API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glucocorticoid API, Product Type & Application
2.7 Global Key Manufacturers of Glucocorticoid API, Date of Enter into This Industry
2.8 Global Glucocorticoid API Market Competitive Situation and Trends
2.8.1 Global Glucocorticoid API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Glucocorticoid API Players Market Share by Revenue
2.8.3 Global Glucocorticoid API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Glucocorticoid API Market Scenario by Region
3.1 Global Glucocorticoid API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Glucocorticoid API Sales by Region: 2019-2030
3.2.1 Global Glucocorticoid API Sales by Region: 2019-2024
3.2.2 Global Glucocorticoid API Sales by Region: 2025-2030
3.3 Global Glucocorticoid API Revenue by Region: 2019-2030
3.3.1 Global Glucocorticoid API Revenue by Region: 2019-2024
3.3.2 Global Glucocorticoid API Revenue by Region: 2025-2030
3.4 North America Glucocorticoid API Market Facts & Figures by Country
3.4.1 North America Glucocorticoid API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Glucocorticoid API Sales by Country (2019-2030)
3.4.3 North America Glucocorticoid API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Glucocorticoid API Market Facts & Figures by Country
3.5.1 Europe Glucocorticoid API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Glucocorticoid API Sales by Country (2019-2030)
3.5.3 Europe Glucocorticoid API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glucocorticoid API Market Facts & Figures by Region
3.6.1 Asia Pacific Glucocorticoid API Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Glucocorticoid API Sales by Region (2019-2030)
3.6.3 Asia Pacific Glucocorticoid API Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Glucocorticoid API Market Facts & Figures by Country
3.7.1 Latin America Glucocorticoid API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Glucocorticoid API Sales by Country (2019-2030)
3.7.3 Latin America Glucocorticoid API Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Glucocorticoid API Market Facts & Figures by Country
3.8.1 Middle East and Africa Glucocorticoid API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Glucocorticoid API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Glucocorticoid API Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glucocorticoid API Sales by Type (2019-2030)
4.1.1 Global Glucocorticoid API Sales by Type (2019-2024)
4.1.2 Global Glucocorticoid API Sales by Type (2025-2030)
4.1.3 Global Glucocorticoid API Sales Market Share by Type (2019-2030)
4.2 Global Glucocorticoid API Revenue by Type (2019-2030)
4.2.1 Global Glucocorticoid API Revenue by Type (2019-2024)
4.2.2 Global Glucocorticoid API Revenue by Type (2025-2030)
4.2.3 Global Glucocorticoid API Revenue Market Share by Type (2019-2030)
4.3 Global Glucocorticoid API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Glucocorticoid API Sales by Application (2019-2030)
5.1.1 Global Glucocorticoid API Sales by Application (2019-2024)
5.1.2 Global Glucocorticoid API Sales by Application (2025-2030)
5.1.3 Global Glucocorticoid API Sales Market Share by Application (2019-2030)
5.2 Global Glucocorticoid API Revenue by Application (2019-2030)
5.2.1 Global Glucocorticoid API Revenue by Application (2019-2024)
5.2.2 Global Glucocorticoid API Revenue by Application (2025-2030)
5.2.3 Global Glucocorticoid API Revenue Market Share by Application (2019-2030)
5.3 Global Glucocorticoid API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer CentreOne
6.1.1 Pfizer CentreOne Company Information
6.1.2 Pfizer CentreOne Description and Business Overview
6.1.3 Pfizer CentreOne Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer CentreOne Glucocorticoid API Product Portfolio
6.1.5 Pfizer CentreOne Recent Developments/Updates
6.2 EUROAPI
6.2.1 EUROAPI Company Information
6.2.2 EUROAPI Description and Business Overview
6.2.3 EUROAPI Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 EUROAPI Glucocorticoid API Product Portfolio
6.2.5 EUROAPI Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Company Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GlaxoSmithKline Glucocorticoid API Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Tianjin Tianyao Pharmaceuticals
6.4.1 Tianjin Tianyao Pharmaceuticals Company Information
6.4.2 Tianjin Tianyao Pharmaceuticals Description and Business Overview
6.4.3 Tianjin Tianyao Pharmaceuticals Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tianjin Tianyao Pharmaceuticals Glucocorticoid API Product Portfolio
6.4.5 Tianjin Tianyao Pharmaceuticals Recent Developments/Updates
6.5 Zhejiang Xianju Pharmaceutical
6.5.1 Zhejiang Xianju Pharmaceutical Company Information
6.5.2 Zhejiang Xianju Pharmaceutical Description and Business Overview
6.5.3 Zhejiang Xianju Pharmaceutical Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zhejiang Xianju Pharmaceutical Glucocorticoid API Product Portfolio
6.5.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
6.6 Henan Lihua Pharmaceutical
6.6.1 Henan Lihua Pharmaceutical Company Information
6.6.2 Henan Lihua Pharmaceutical Description and Business Overview
6.6.3 Henan Lihua Pharmaceutical Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Henan Lihua Pharmaceutical Glucocorticoid API Product Portfolio
6.6.5 Henan Lihua Pharmaceutical Recent Developments/Updates
6.7 Symbiotec Pharmalab
6.7.1 Symbiotec Pharmalab Company Information
6.7.2 Symbiotec Pharmalab Description and Business Overview
6.7.3 Symbiotec Pharmalab Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Symbiotec Pharmalab Glucocorticoid API Product Portfolio
6.7.5 Symbiotec Pharmalab Recent Developments/Updates
6.8 Sun Pharmaceutical
6.8.1 Sun Pharmaceutical Company Information
6.8.2 Sun Pharmaceutical Description and Business Overview
6.8.3 Sun Pharmaceutical Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sun Pharmaceutical Glucocorticoid API Product Portfolio
6.8.5 Sun Pharmaceutical Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Company Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cipla Glucocorticoid API Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Hovione
6.10.1 Hovione Company Information
6.10.2 Hovione Description and Business Overview
6.10.3 Hovione Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hovione Glucocorticoid API Product Portfolio
6.10.5 Hovione Recent Developments/Updates
6.11 Shandong Xinhua Pharmaceutical
6.11.1 Shandong Xinhua Pharmaceutical Company Information
6.11.2 Shandong Xinhua Pharmaceutical Description and Business Overview
6.11.3 Shandong Xinhua Pharmaceutical Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shandong Xinhua Pharmaceutical Glucocorticoid API Product Portfolio
6.11.5 Shandong Xinhua Pharmaceutical Recent Developments/Updates
6.12 Steroid SpA
6.12.1 Steroid SpA Company Information
6.12.2 Steroid SpA Description and Business Overview
6.12.3 Steroid SpA Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Steroid SpA Glucocorticoid API Product Portfolio
6.12.5 Steroid SpA Recent Developments/Updates
6.13 Avik Pharmaceutical
6.13.1 Avik Pharmaceutical Company Information
6.13.2 Avik Pharmaceutical Description and Business Overview
6.13.3 Avik Pharmaceutical Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Avik Pharmaceutical Glucocorticoid API Product Portfolio
6.13.5 Avik Pharmaceutical Recent Developments/Updates
6.14 Great Pacific Exports
6.14.1 Great Pacific Exports Company Information
6.14.2 Great Pacific Exports Description and Business Overview
6.14.3 Great Pacific Exports Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Great Pacific Exports Glucocorticoid API Product Portfolio
6.14.5 Great Pacific Exports Recent Developments/Updates
6.15 Shanghai New Hualian Pharmaceutical
6.15.1 Shanghai New Hualian Pharmaceutical Company Information
6.15.2 Shanghai New Hualian Pharmaceutical Description and Business Overview
6.15.3 Shanghai New Hualian Pharmaceutical Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shanghai New Hualian Pharmaceutical Glucocorticoid API Product Portfolio
6.15.5 Shanghai New Hualian Pharmaceutical Recent Developments/Updates
6.16 Shandong Taihua Biotech
6.16.1 Shandong Taihua Biotech Company Information
6.16.2 Shandong Taihua Biotech Description and Business Overview
6.16.3 Shandong Taihua Biotech Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Shandong Taihua Biotech Glucocorticoid API Product Portfolio
6.16.5 Shandong Taihua Biotech Recent Developments/Updates
6.17 Tianjin Pacific Pharmaceutical
6.17.1 Tianjin Pacific Pharmaceutical Company Information
6.17.2 Tianjin Pacific Pharmaceutical Description and Business Overview
6.17.3 Tianjin Pacific Pharmaceutical Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Tianjin Pacific Pharmaceutical Glucocorticoid API Product Portfolio
6.17.5 Tianjin Pacific Pharmaceutical Recent Developments/Updates
6.18 Teva
6.18.1 Teva Company Information
6.18.2 Teva Description and Business Overview
6.18.3 Teva Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Teva Glucocorticoid API Product Portfolio
6.18.5 Teva Recent Developments/Updates
6.19 Zhejiang Xianju Xianle Pharmaceutical
6.19.1 Zhejiang Xianju Xianle Pharmaceutical Company Information
6.19.2 Zhejiang Xianju Xianle Pharmaceutical Description and Business Overview
6.19.3 Zhejiang Xianju Xianle Pharmaceutical Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Zhejiang Xianju Xianle Pharmaceutical Glucocorticoid API Product Portfolio
6.19.5 Zhejiang Xianju Xianle Pharmaceutical Recent Developments/Updates
6.20 Jiangsu Lianhuan Pharmaceutical
6.20.1 Jiangsu Lianhuan Pharmaceutical Company Information
6.20.2 Jiangsu Lianhuan Pharmaceutical Description and Business Overview
6.20.3 Jiangsu Lianhuan Pharmaceutical Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Jiangsu Lianhuan Pharmaceutical Glucocorticoid API Product Portfolio
6.20.5 Jiangsu Lianhuan Pharmaceutical Recent Developments/Updates
6.21 Saituo Biological Technology
6.21.1 Saituo Biological Technology Company Information
6.21.2 Saituo Biological Technology Description and Business Overview
6.21.3 Saituo Biological Technology Glucocorticoid API Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Saituo Biological Technology Glucocorticoid API Product Portfolio
6.21.5 Saituo Biological Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glucocorticoid API Industry Chain Analysis
7.2 Glucocorticoid API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glucocorticoid API Production Mode & Process
7.4 Glucocorticoid API Sales and Marketing
7.4.1 Glucocorticoid API Sales Channels
7.4.2 Glucocorticoid API Distributors
7.5 Glucocorticoid API Customers
8 Glucocorticoid API Market Dynamics
8.1 Glucocorticoid API Industry Trends
8.2 Glucocorticoid API Market Drivers
8.3 Glucocorticoid API Market Challenges
8.4 Glucocorticoid API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Glucocorticoid API Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Glucocorticoid API Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Glucocorticoid API Market Competitive Situation by Manufacturers in 2023
Table 4. Global Glucocorticoid API Sales (Tons) of Key Manufacturers (2019-2024)
Table 5. Global Glucocorticoid API Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Glucocorticoid API Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Glucocorticoid API Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Glucocorticoid API Average Price (US$/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Glucocorticoid API, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Glucocorticoid API, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Glucocorticoid API, Product Type & Application
Table 12. Global Key Manufacturers of Glucocorticoid API, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Glucocorticoid API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucocorticoid API as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Glucocorticoid API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Glucocorticoid API Sales by Region (2019-2024) & (Tons)
Table 18. Global Glucocorticoid API Sales Market Share by Region (2019-2024)
Table 19. Global Glucocorticoid API Sales by Region (2025-2030) & (Tons)
Table 20. Global Glucocorticoid API Sales Market Share by Region (2025-2030)
Table 21. Global Glucocorticoid API Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Glucocorticoid API Revenue Market Share by Region (2019-2024)
Table 23. Global Glucocorticoid API Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Glucocorticoid API Revenue Market Share by Region (2025-2030)
Table 25. North America Glucocorticoid API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Glucocorticoid API Sales by Country (2019-2024) & (Tons)
Table 27. North America Glucocorticoid API Sales by Country (2025-2030) & (Tons)
Table 28. North America Glucocorticoid API Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Glucocorticoid API Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Glucocorticoid API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Glucocorticoid API Sales by Country (2019-2024) & (Tons)
Table 32. Europe Glucocorticoid API Sales by Country (2025-2030) & (Tons)
Table 33. Europe Glucocorticoid API Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Glucocorticoid API Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Glucocorticoid API Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Glucocorticoid API Sales by Region (2019-2024) & (Tons)
Table 37. Asia Pacific Glucocorticoid API Sales by Region (2025-2030) & (Tons)
Table 38. Asia Pacific Glucocorticoid API Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Glucocorticoid API Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Glucocorticoid API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Glucocorticoid API Sales by Country (2019-2024) & (Tons)
Table 42. Latin America Glucocorticoid API Sales by Country (2025-2030) & (Tons)
Table 43. Latin America Glucocorticoid API Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Glucocorticoid API Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Glucocorticoid API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Glucocorticoid API Sales by Country (2019-2024) & (Tons)
Table 47. Middle East and Africa Glucocorticoid API Sales by Country (2025-2030) & (Tons)
Table 48. Middle East and Africa Glucocorticoid API Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Glucocorticoid API Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Glucocorticoid API Sales (Tons) by Type (2019-2024)
Table 51. Global Glucocorticoid API Sales (Tons) by Type (2025-2030)
Table 52. Global Glucocorticoid API Sales Market Share by Type (2019-2024)
Table 53. Global Glucocorticoid API Sales Market Share by Type (2025-2030)
Table 54. Global Glucocorticoid API Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Glucocorticoid API Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Glucocorticoid API Revenue Market Share by Type (2019-2024)
Table 57. Global Glucocorticoid API Revenue Market Share by Type (2025-2030)
Table 58. Global Glucocorticoid API Price (US$/Kg) by Type (2019-2024)
Table 59. Global Glucocorticoid API Price (US$/Kg) by Type (2025-2030)
Table 60. Global Glucocorticoid API Sales (Tons) by Application (2019-2024)
Table 61. Global Glucocorticoid API Sales (Tons) by Application (2025-2030)
Table 62. Global Glucocorticoid API Sales Market Share by Application (2019-2024)
Table 63. Global Glucocorticoid API Sales Market Share by Application (2025-2030)
Table 64. Global Glucocorticoid API Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Glucocorticoid API Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Glucocorticoid API Revenue Market Share by Application (2019-2024)
Table 67. Global Glucocorticoid API Revenue Market Share by Application (2025-2030)
Table 68. Global Glucocorticoid API Price (US$/Kg) by Application (2019-2024)
Table 69. Global Glucocorticoid API Price (US$/Kg) by Application (2025-2030)
Table 70. Pfizer CentreOne Company Information
Table 71. Pfizer CentreOne Description and Business Overview
Table 72. Pfizer CentreOne Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. Pfizer CentreOne Glucocorticoid API Product
Table 74. Pfizer CentreOne Recent Developments/Updates
Table 75. EUROAPI Company Information
Table 76. EUROAPI Description and Business Overview
Table 77. EUROAPI Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. EUROAPI Glucocorticoid API Product
Table 79. EUROAPI Recent Developments/Updates
Table 80. GlaxoSmithKline Company Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. GlaxoSmithKline Glucocorticoid API Product
Table 84. GlaxoSmithKline Recent Developments/Updates
Table 85. Tianjin Tianyao Pharmaceuticals Company Information
Table 86. Tianjin Tianyao Pharmaceuticals Description and Business Overview
Table 87. Tianjin Tianyao Pharmaceuticals Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. Tianjin Tianyao Pharmaceuticals Glucocorticoid API Product
Table 89. Tianjin Tianyao Pharmaceuticals Recent Developments/Updates
Table 90. Zhejiang Xianju Pharmaceutical Company Information
Table 91. Zhejiang Xianju Pharmaceutical Description and Business Overview
Table 92. Zhejiang Xianju Pharmaceutical Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. Zhejiang Xianju Pharmaceutical Glucocorticoid API Product
Table 94. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
Table 95. Henan Lihua Pharmaceutical Company Information
Table 96. Henan Lihua Pharmaceutical Description and Business Overview
Table 97. Henan Lihua Pharmaceutical Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. Henan Lihua Pharmaceutical Glucocorticoid API Product
Table 99. Henan Lihua Pharmaceutical Recent Developments/Updates
Table 100. Symbiotec Pharmalab Company Information
Table 101. Symbiotec Pharmalab Description and Business Overview
Table 102. Symbiotec Pharmalab Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 103. Symbiotec Pharmalab Glucocorticoid API Product
Table 104. Symbiotec Pharmalab Recent Developments/Updates
Table 105. Sun Pharmaceutical Company Information
Table 106. Sun Pharmaceutical Description and Business Overview
Table 107. Sun Pharmaceutical Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 108. Sun Pharmaceutical Glucocorticoid API Product
Table 109. Sun Pharmaceutical Recent Developments/Updates
Table 110. Cipla Company Information
Table 111. Cipla Description and Business Overview
Table 112. Cipla Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 113. Cipla Glucocorticoid API Product
Table 114. Cipla Recent Developments/Updates
Table 115. Hovione Company Information
Table 116. Hovione Description and Business Overview
Table 117. Hovione Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 118. Hovione Glucocorticoid API Product
Table 119. Hovione Recent Developments/Updates
Table 120. Shandong Xinhua Pharmaceutical Company Information
Table 121. Shandong Xinhua Pharmaceutical Description and Business Overview
Table 122. Shandong Xinhua Pharmaceutical Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 123. Shandong Xinhua Pharmaceutical Glucocorticoid API Product
Table 124. Shandong Xinhua Pharmaceutical Recent Developments/Updates
Table 125. Steroid SpA Company Information
Table 126. Steroid SpA Description and Business Overview
Table 127. Steroid SpA Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 128. Steroid SpA Glucocorticoid API Product
Table 129. Steroid SpA Recent Developments/Updates
Table 130. Avik Pharmaceutical Company Information
Table 131. Avik Pharmaceutical Description and Business Overview
Table 132. Avik Pharmaceutical Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 133. Avik Pharmaceutical Glucocorticoid API Product
Table 134. Avik Pharmaceutical Recent Developments/Updates
Table 135. Great Pacific Exports Company Information
Table 136. Great Pacific Exports Description and Business Overview
Table 137. Great Pacific Exports Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 138. Great Pacific Exports Glucocorticoid API Product
Table 139. Great Pacific Exports Recent Developments/Updates
Table 140. Shanghai New Hualian Pharmaceutical Company Information
Table 141. Shanghai New Hualian Pharmaceutical Description and Business Overview
Table 142. Shanghai New Hualian Pharmaceutical Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 143. Shanghai New Hualian Pharmaceutical Glucocorticoid API Product
Table 144. Shanghai New Hualian Pharmaceutical Recent Developments/Updates
Table 145. Shandong Taihua Biotech Company Information
Table 146. Shandong Taihua Biotech Description and Business Overview
Table 147. Shandong Taihua Biotech Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 148. Shandong Taihua Biotech Glucocorticoid API Product
Table 149. Shandong Taihua Biotech Recent Developments/Updates
Table 150. Tianjin Pacific Pharmaceutical Company Information
Table 151. Tianjin Pacific Pharmaceutical Description and Business Overview
Table 152. Tianjin Pacific Pharmaceutical Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 153. Tianjin Pacific Pharmaceutical Glucocorticoid API Product
Table 154. Tianjin Pacific Pharmaceutical Recent Developments/Updates
Table 155. Teva Company Information
Table 156. Teva Description and Business Overview
Table 157. Teva Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 158. Teva Glucocorticoid API Product
Table 159. Teva Recent Developments/Updates
Table 160. Zhejiang Xianju Xianle Pharmaceutical Company Information
Table 161. Zhejiang Xianju Xianle Pharmaceutical Description and Business Overview
Table 162. Zhejiang Xianju Xianle Pharmaceutical Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 163. Zhejiang Xianju Xianle Pharmaceutical Glucocorticoid API Product
Table 164. Zhejiang Xianju Xianle Pharmaceutical Recent Developments/Updates
Table 165. Jiangsu Lianhuan Pharmaceutical Company Information
Table 166. Jiangsu Lianhuan Pharmaceutical Description and Business Overview
Table 167. Jiangsu Lianhuan Pharmaceutical Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 168. Jiangsu Lianhuan Pharmaceutical Glucocorticoid API Product
Table 169. Jiangsu Lianhuan Pharmaceutical Recent Developments/Updates
Table 170. Saituo Biological Technology Company Information
Table 171. Saituo Biological Technology Description and Business Overview
Table 172. Saituo Biological Technology Glucocorticoid API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 173. Saituo Biological Technology Glucocorticoid API Product
Table 174. Saituo Biological Technology Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Glucocorticoid API Distributors List
Table 178. Glucocorticoid API Customers List
Table 179. Glucocorticoid API Market Trends
Table 180. Glucocorticoid API Market Drivers
Table 181. Glucocorticoid API Market Challenges
Table 182. Glucocorticoid API Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of Glucocorticoid API
Figure 2. Global Glucocorticoid API Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Glucocorticoid API Market Share by Type: 2023 & 2030
Figure 4. Prednisone Series Product Picture
Figure 5. Dexamethasone Series Product Picture
Figure 6. Methylprednisolone Series Product Picture
Figure 7. Prednisolone Series Product Picture
Figure 8. Hydrocortisone Series Product Picture
Figure 9. Others Product Picture
Figure 10. Global Glucocorticoid API Market Value by Application (2024-2030) & (US$ Million)
Figure 11. Global Glucocorticoid API Market Share by Application: 2023 & 2030
Figure 12. Injectable Preparations
Figure 13. Oral Preparations
Figure 14. Topical Preparations
Figure 15. Inhaled Preparations
Figure 16. Global Glucocorticoid API Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Glucocorticoid API Market Size (2019-2030) & (US$ Million)
Figure 18. Global Glucocorticoid API Sales (2019-2030) & (Tons)
Figure 19. Global Glucocorticoid API Average Price (US$/Kg) & (2019-2030)
Figure 20. Glucocorticoid API Report Years Considered
Figure 21. Glucocorticoid API Sales Share by Manufacturers in 2023
Figure 22. Global Glucocorticoid API Revenue Share by Manufacturers in 2023
Figure 23. Global 5 and 10 Largest Glucocorticoid API Players: Market Share by Revenue in Glucocorticoid API in 2023
Figure 24. Glucocorticoid API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 25. Global Glucocorticoid API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Glucocorticoid API Sales Market Share by Country (2019-2030)
Figure 27. North America Glucocorticoid API Revenue Market Share by Country (2019-2030)
Figure 28. United States Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Glucocorticoid API Sales Market Share by Country (2019-2030)
Figure 31. Europe Glucocorticoid API Revenue Market Share by Country (2019-2030)
Figure 32. Germany Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Glucocorticoid API Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Glucocorticoid API Revenue Market Share by Region (2019-2030)
Figure 39. China Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. China Taiwan Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Glucocorticoid API Sales Market Share by Country (2019-2030)
Figure 47. Mexico Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Colombia Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East and Africa Glucocorticoid API Sales Market Share by Country (2019-2030)
Figure 52. Middle East and Africa Glucocorticoid API Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Glucocorticoid API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Glucocorticoid API by Type (2019-2030)
Figure 57. Global Revenue Market Share of Glucocorticoid API by Type (2019-2030)
Figure 58. Global Glucocorticoid API Price (US$/Kg) by Type (2019-2030)
Figure 59. Global Sales Market Share of Glucocorticoid API by Application (2019-2030)
Figure 60. Global Revenue Market Share of Glucocorticoid API by Application (2019-2030)
Figure 61. Global Glucocorticoid API Price (US$/Kg) by Application (2019-2030)
Figure 62. Glucocorticoid API Value Chain
Figure 63. Glucocorticoid API Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
